Mallinckrodt Denies Manipulating Acthar Market
By Rick Archer · November 17, 2021, 8:55 PM EST
Mallinckrodt closed its defense against claims it inflated the price of its Acthar gel on Wednesday, with witnesses saying that the drugmaker didn't suppress a competing product and that the speaking fees...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login